Table 3.
Deaths by cause and race/ethnicity.
| Number died during study | White (n=30,993) | Black (n=4,997) | Hispanic (n=2,121) | Other (n=967) |
|---|---|---|---|---|
| 11,264 (36.3) | 1,857 (37.2) | 630 (29.7) | 267 (29.2) | |
| Cause of death | ||||
| Cardiovascular | 2,269 (20.1) | 566 (30.5) | 139 (17.8) | 73 (25.9) |
| Graft failure | 1,998 (17.7) | 509 (27.4) | 139 (22.1) | 51 (18.1) |
| Infection | 1,930 (17.1) | 255 (13.7) | 112 (17.8) | 61 (21.6) |
| Non-PTLD malignancy | 1,403 (12.5) | 92 (5.0) | 42 (6.7) | 12 (4.3) |
| Pulmonary | 626 (5.6) | 70 (3.8) | 34 (5.4) | 12 (4.3) |
| Renal failure | 510 (4.5) | 66 (3.6) | 14 (2.2) | 6 (2.1) |
| Cerebrovascular | 493 (4.4) | 67 (3.6) | 24 (3.8) | 11 (3.9) |
| PTLD or lymphoma | 388 (3.4) | 22 (1.2) | 18 (2.9) | 12 (4.3) |
| Hemorrhage | 241 (2.1) | 38 (2.1) | 13 (2.1) | 6 (2.1) |
| Accident, trauma, or suicide | 144 (1.3) | 13 (0.7) | 6 (1.0) | 1 (0.4) |
| Non-compliance | 71 (0.6) | 41 (2.2) | 15 (2.4) | 1 (0.4) |
| Other | 1,189 (10.6) | 118 (6.4) | 74 (11.8) | 36 (12.8) |
Chi-squared for comparison between racial subgroups < 0.001. PTLD: post-transplant lymphoproliferative disorder